US2017164949A1PendingUtilityA1

Vessel flow control devices and methods

50
Assignee: CARRISON HAROLDPriority: Aug 3, 2012Filed: Dec 22, 2016Published: Jun 15, 2017
Est. expiryAug 3, 2032(~6.1 yrs left)· nominal 20-yr term from priority
Inventors:Harold Carrison
A61F 2250/0031A61F 2/86A61B 17/12027A61B 17/12036A61B 2017/00004A61B 17/12045A61B 17/12177A61B 17/12031A61B 17/12136A61F 2/90A61B 17/12109A61B 17/1204A61B 2090/064A61F 2002/068
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods for treating an afflicted vessel and/or vessel associated with an afflicted tissue of a mammalian patient are presented herein. In particular, devices for the control of flow rate and/or pressure within a vessel of a mammalian patient, and methods of treating an afflicted vessel and/or a vessel associated with an afflicted tissue using the devices are presented herein.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A vessel flow control device for controlling at least one of a flow rate or a pressure within a lumen of a vessel of a mammalian patient during a treatment of an afflicted region of the vessel, the lumen including a cross-sectional area, the device comprising:
 a variable occlusion element configured for placement within the lumen and to assume a plurality of occlusion states within the lumen, each occlusion state including an occlusion factor ranging from about five percent to about one hundred percent, wherein the occlusion factor is a percentage of the lumen cross-sectional area occluded by a cross-sectional area of the variable occlusion element and an occlusion factor of one hundred percent corresponds to a complete blockage of flow through the vessel;   a mechanism configured to cause the variable occlusion element to selectively transition between the plurality of occlusion states; and   a control sequence for the mechanism selectively transitioning the variable occlusion element between the plurality of occlusion states, the control sequence comprising obtaining a measurement of vascular leakage from the afflicted region, and causing the mechanism to selectively transition the variable occlusion element such that a subsequent occlusion state has: a lower occlusion factor than a current occlusion state if the measurement indicates no vascular leakage; and a higher occlusion factor than the current occlusion state if the measurement indicates vascular leakage.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.